Loading…

Curcumin Attenuates Renal Ischemia and Reperfusion Injury–Induced Restrictive Respiratory Insufficiency

Abstract Objective Pulmonary failure, instead of kidney failure, is one of the leading causes of acute kidney injury (AKI)-related death. Volume overload was previously regarded as the primary cause of lung injury, presumably by impaired renal fluid clearance. Recent evidence suggested that proinfla...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2013-12, Vol.45 (10), p.3542-3545
Main Authors: Yeh, J.-H, Yang, Y.-C, Wang, J.-C, Wang, D, Wang, J.-J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983
cites cdi_FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983
container_end_page 3545
container_issue 10
container_start_page 3542
container_title Transplantation proceedings
container_volume 45
creator Yeh, J.-H
Yang, Y.-C
Wang, J.-C
Wang, D
Wang, J.-J
description Abstract Objective Pulmonary failure, instead of kidney failure, is one of the leading causes of acute kidney injury (AKI)-related death. Volume overload was previously regarded as the primary cause of lung injury, presumably by impaired renal fluid clearance. Recent evidence suggested that proinflammatory cytokines, chemokines, and free radicals released during AKI are playing a crucial role in the lung injury. We aimed to examine the protective efficacy of lung function with curcumin pretreatment. Methods AKI was induced by 45 minutes of kidney ischemia (bilateral occlusion of renal pedicles) followed by 3 hours of reperfusion. Rats were divided into 3 groups: sham-operated, kidney ischemia and reperfusion (I/R), and a group with 2 days of oral pretreatment with curcumin (12.5 mg/kg/d) before I/R injury. The pulmonary function test (PFT) was conducted at baseline and after 3 hours of reperfusion, yielding parameters of lung volumes, chord compliance (Cchord), inspiratory resistance (RI), and forced expiratory volume at the first 200 millisecond (FEV200 ). We also examined levels of protein concentration (PC), methylguanidine (MG), tumor necrosis factor-α (TNF-α), and malondialdehyde (MDA) in the bronchoalveolar lavage (BAL). Results Ischemic AKI-induced restrictive lung disease was demonstrated by the decreased Cchord, total lung capacitance (TLC), and FEV200 , in addition to the increased lavage PCBAL, MG, TNF-α, and MDA level. Curcumin pretreatment ameliorated lung function impairment and alveolar vascular protein leak and attenuated lung inflammation. Conclusions The protective effect of curcumin pretreatment against restrictive lung disease is most likely associated with decreasing hydroxyl radical, lipid peroxidation, and inflammation in the lungs and improving alveolar vascular permeability.
doi_str_mv 10.1016/j.transproceed.2013.09.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1466373998</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134513009147</els_id><sourcerecordid>1466373998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983</originalsourceid><addsrcrecordid>eNqNkctu1TAQhi0EoofCK6CIFZsEO3ZuLJCqw-1IlZC4rC1nPBYOiXOw40rZ9R36hjwJDqeVqq7Y2J6Zf2Y83xDyitGCUVa_GYrFKxeOfgZEXZSU8YJ2BaXiEdmxtuF5WZf8MdklD8sZF9UZeRbCQJNdCv6UnKWTia4SO2L30UOcrMsulgVdVAuG7Cs6NWaHAD9xsipTTifXEb2Jwc4uO7gh-vXP9c3B6Qi4BcPiLSz2Crf30Xq1zH5NwhCNsWDRwfqcPDFqDPji9j4nPz5--L7_nF9--XTYX1zmIHi15Ix1qq5LqLGDSgMorSutsFGtKk3bN01pGiUagVCqHnUPpuNtLww1dVV3XcvPyetT3cTnd0w_k5MNgOOoHM4xSCbqmjf8JH17koKfQ_Bo5NHbSflVMio31HKQ91HLDbWknUwgU_LL2z6xn1LsLvWObRK8PwkwTXtl0cvwjwRq6xEWqWf7f33ePSgDo3UW1PgLVwzDHH3aVppLhlJS-W1b-rZzxintmGj4X3UDsBg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1466373998</pqid></control><display><type>article</type><title>Curcumin Attenuates Renal Ischemia and Reperfusion Injury–Induced Restrictive Respiratory Insufficiency</title><source>ScienceDirect Journals</source><creator>Yeh, J.-H ; Yang, Y.-C ; Wang, J.-C ; Wang, D ; Wang, J.-J</creator><creatorcontrib>Yeh, J.-H ; Yang, Y.-C ; Wang, J.-C ; Wang, D ; Wang, J.-J</creatorcontrib><description>Abstract Objective Pulmonary failure, instead of kidney failure, is one of the leading causes of acute kidney injury (AKI)-related death. Volume overload was previously regarded as the primary cause of lung injury, presumably by impaired renal fluid clearance. Recent evidence suggested that proinflammatory cytokines, chemokines, and free radicals released during AKI are playing a crucial role in the lung injury. We aimed to examine the protective efficacy of lung function with curcumin pretreatment. Methods AKI was induced by 45 minutes of kidney ischemia (bilateral occlusion of renal pedicles) followed by 3 hours of reperfusion. Rats were divided into 3 groups: sham-operated, kidney ischemia and reperfusion (I/R), and a group with 2 days of oral pretreatment with curcumin (12.5 mg/kg/d) before I/R injury. The pulmonary function test (PFT) was conducted at baseline and after 3 hours of reperfusion, yielding parameters of lung volumes, chord compliance (Cchord), inspiratory resistance (RI), and forced expiratory volume at the first 200 millisecond (FEV200 ). We also examined levels of protein concentration (PC), methylguanidine (MG), tumor necrosis factor-α (TNF-α), and malondialdehyde (MDA) in the bronchoalveolar lavage (BAL). Results Ischemic AKI-induced restrictive lung disease was demonstrated by the decreased Cchord, total lung capacitance (TLC), and FEV200 , in addition to the increased lavage PCBAL, MG, TNF-α, and MDA level. Curcumin pretreatment ameliorated lung function impairment and alveolar vascular protein leak and attenuated lung inflammation. Conclusions The protective effect of curcumin pretreatment against restrictive lung disease is most likely associated with decreasing hydroxyl radical, lipid peroxidation, and inflammation in the lungs and improving alveolar vascular permeability.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2013.09.004</identifier><identifier>PMID: 24314954</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Kidney Injury - drug therapy ; Acute Kidney Injury - metabolism ; Acute Kidney Injury - physiopathology ; Airway Resistance ; Animals ; Anti-Inflammatory Agents - pharmacology ; Antioxidants - pharmacology ; Bronchoalveolar Lavage Fluid - chemistry ; Capillary Permeability - drug effects ; Curcumin - pharmacology ; Cytoprotection ; Disease Models, Animal ; Forced Expiratory Volume - drug effects ; Kidney - blood supply ; Lipid Peroxidation - drug effects ; Lung - blood supply ; Lung - drug effects ; Lung - metabolism ; Lung - physiopathology ; Lung Compliance - drug effects ; Malondialdehyde - metabolism ; Methylguanidine - metabolism ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury - drug therapy ; Reperfusion Injury - metabolism ; Reperfusion Injury - physiopathology ; Respiratory Insufficiency - metabolism ; Respiratory Insufficiency - physiopathology ; Respiratory Insufficiency - prevention &amp; control ; Surgery ; Total Lung Capacity - drug effects ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Transplantation proceedings, 2013-12, Vol.45 (10), p.3542-3545</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983</citedby><cites>FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24314954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yeh, J.-H</creatorcontrib><creatorcontrib>Yang, Y.-C</creatorcontrib><creatorcontrib>Wang, J.-C</creatorcontrib><creatorcontrib>Wang, D</creatorcontrib><creatorcontrib>Wang, J.-J</creatorcontrib><title>Curcumin Attenuates Renal Ischemia and Reperfusion Injury–Induced Restrictive Respiratory Insufficiency</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Objective Pulmonary failure, instead of kidney failure, is one of the leading causes of acute kidney injury (AKI)-related death. Volume overload was previously regarded as the primary cause of lung injury, presumably by impaired renal fluid clearance. Recent evidence suggested that proinflammatory cytokines, chemokines, and free radicals released during AKI are playing a crucial role in the lung injury. We aimed to examine the protective efficacy of lung function with curcumin pretreatment. Methods AKI was induced by 45 minutes of kidney ischemia (bilateral occlusion of renal pedicles) followed by 3 hours of reperfusion. Rats were divided into 3 groups: sham-operated, kidney ischemia and reperfusion (I/R), and a group with 2 days of oral pretreatment with curcumin (12.5 mg/kg/d) before I/R injury. The pulmonary function test (PFT) was conducted at baseline and after 3 hours of reperfusion, yielding parameters of lung volumes, chord compliance (Cchord), inspiratory resistance (RI), and forced expiratory volume at the first 200 millisecond (FEV200 ). We also examined levels of protein concentration (PC), methylguanidine (MG), tumor necrosis factor-α (TNF-α), and malondialdehyde (MDA) in the bronchoalveolar lavage (BAL). Results Ischemic AKI-induced restrictive lung disease was demonstrated by the decreased Cchord, total lung capacitance (TLC), and FEV200 , in addition to the increased lavage PCBAL, MG, TNF-α, and MDA level. Curcumin pretreatment ameliorated lung function impairment and alveolar vascular protein leak and attenuated lung inflammation. Conclusions The protective effect of curcumin pretreatment against restrictive lung disease is most likely associated with decreasing hydroxyl radical, lipid peroxidation, and inflammation in the lungs and improving alveolar vascular permeability.</description><subject>Acute Kidney Injury - drug therapy</subject><subject>Acute Kidney Injury - metabolism</subject><subject>Acute Kidney Injury - physiopathology</subject><subject>Airway Resistance</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antioxidants - pharmacology</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Capillary Permeability - drug effects</subject><subject>Curcumin - pharmacology</subject><subject>Cytoprotection</subject><subject>Disease Models, Animal</subject><subject>Forced Expiratory Volume - drug effects</subject><subject>Kidney - blood supply</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Lung - blood supply</subject><subject>Lung - drug effects</subject><subject>Lung - metabolism</subject><subject>Lung - physiopathology</subject><subject>Lung Compliance - drug effects</subject><subject>Malondialdehyde - metabolism</subject><subject>Methylguanidine - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - physiopathology</subject><subject>Respiratory Insufficiency - metabolism</subject><subject>Respiratory Insufficiency - physiopathology</subject><subject>Respiratory Insufficiency - prevention &amp; control</subject><subject>Surgery</subject><subject>Total Lung Capacity - drug effects</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkctu1TAQhi0EoofCK6CIFZsEO3ZuLJCqw-1IlZC4rC1nPBYOiXOw40rZ9R36hjwJDqeVqq7Y2J6Zf2Y83xDyitGCUVa_GYrFKxeOfgZEXZSU8YJ2BaXiEdmxtuF5WZf8MdklD8sZF9UZeRbCQJNdCv6UnKWTia4SO2L30UOcrMsulgVdVAuG7Cs6NWaHAD9xsipTTifXEb2Jwc4uO7gh-vXP9c3B6Qi4BcPiLSz2Crf30Xq1zH5NwhCNsWDRwfqcPDFqDPji9j4nPz5--L7_nF9--XTYX1zmIHi15Ix1qq5LqLGDSgMorSutsFGtKk3bN01pGiUagVCqHnUPpuNtLww1dVV3XcvPyetT3cTnd0w_k5MNgOOoHM4xSCbqmjf8JH17koKfQ_Bo5NHbSflVMio31HKQ91HLDbWknUwgU_LL2z6xn1LsLvWObRK8PwkwTXtl0cvwjwRq6xEWqWf7f33ePSgDo3UW1PgLVwzDHH3aVppLhlJS-W1b-rZzxintmGj4X3UDsBg</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Yeh, J.-H</creator><creator>Yang, Y.-C</creator><creator>Wang, J.-C</creator><creator>Wang, D</creator><creator>Wang, J.-J</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Curcumin Attenuates Renal Ischemia and Reperfusion Injury–Induced Restrictive Respiratory Insufficiency</title><author>Yeh, J.-H ; Yang, Y.-C ; Wang, J.-C ; Wang, D ; Wang, J.-J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acute Kidney Injury - drug therapy</topic><topic>Acute Kidney Injury - metabolism</topic><topic>Acute Kidney Injury - physiopathology</topic><topic>Airway Resistance</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antioxidants - pharmacology</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Capillary Permeability - drug effects</topic><topic>Curcumin - pharmacology</topic><topic>Cytoprotection</topic><topic>Disease Models, Animal</topic><topic>Forced Expiratory Volume - drug effects</topic><topic>Kidney - blood supply</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Lung - blood supply</topic><topic>Lung - drug effects</topic><topic>Lung - metabolism</topic><topic>Lung - physiopathology</topic><topic>Lung Compliance - drug effects</topic><topic>Malondialdehyde - metabolism</topic><topic>Methylguanidine - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - physiopathology</topic><topic>Respiratory Insufficiency - metabolism</topic><topic>Respiratory Insufficiency - physiopathology</topic><topic>Respiratory Insufficiency - prevention &amp; control</topic><topic>Surgery</topic><topic>Total Lung Capacity - drug effects</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeh, J.-H</creatorcontrib><creatorcontrib>Yang, Y.-C</creatorcontrib><creatorcontrib>Wang, J.-C</creatorcontrib><creatorcontrib>Wang, D</creatorcontrib><creatorcontrib>Wang, J.-J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeh, J.-H</au><au>Yang, Y.-C</au><au>Wang, J.-C</au><au>Wang, D</au><au>Wang, J.-J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Curcumin Attenuates Renal Ischemia and Reperfusion Injury–Induced Restrictive Respiratory Insufficiency</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>45</volume><issue>10</issue><spage>3542</spage><epage>3545</epage><pages>3542-3545</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><abstract>Abstract Objective Pulmonary failure, instead of kidney failure, is one of the leading causes of acute kidney injury (AKI)-related death. Volume overload was previously regarded as the primary cause of lung injury, presumably by impaired renal fluid clearance. Recent evidence suggested that proinflammatory cytokines, chemokines, and free radicals released during AKI are playing a crucial role in the lung injury. We aimed to examine the protective efficacy of lung function with curcumin pretreatment. Methods AKI was induced by 45 minutes of kidney ischemia (bilateral occlusion of renal pedicles) followed by 3 hours of reperfusion. Rats were divided into 3 groups: sham-operated, kidney ischemia and reperfusion (I/R), and a group with 2 days of oral pretreatment with curcumin (12.5 mg/kg/d) before I/R injury. The pulmonary function test (PFT) was conducted at baseline and after 3 hours of reperfusion, yielding parameters of lung volumes, chord compliance (Cchord), inspiratory resistance (RI), and forced expiratory volume at the first 200 millisecond (FEV200 ). We also examined levels of protein concentration (PC), methylguanidine (MG), tumor necrosis factor-α (TNF-α), and malondialdehyde (MDA) in the bronchoalveolar lavage (BAL). Results Ischemic AKI-induced restrictive lung disease was demonstrated by the decreased Cchord, total lung capacitance (TLC), and FEV200 , in addition to the increased lavage PCBAL, MG, TNF-α, and MDA level. Curcumin pretreatment ameliorated lung function impairment and alveolar vascular protein leak and attenuated lung inflammation. Conclusions The protective effect of curcumin pretreatment against restrictive lung disease is most likely associated with decreasing hydroxyl radical, lipid peroxidation, and inflammation in the lungs and improving alveolar vascular permeability.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24314954</pmid><doi>10.1016/j.transproceed.2013.09.004</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2013-12, Vol.45 (10), p.3542-3545
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_1466373998
source ScienceDirect Journals
subjects Acute Kidney Injury - drug therapy
Acute Kidney Injury - metabolism
Acute Kidney Injury - physiopathology
Airway Resistance
Animals
Anti-Inflammatory Agents - pharmacology
Antioxidants - pharmacology
Bronchoalveolar Lavage Fluid - chemistry
Capillary Permeability - drug effects
Curcumin - pharmacology
Cytoprotection
Disease Models, Animal
Forced Expiratory Volume - drug effects
Kidney - blood supply
Lipid Peroxidation - drug effects
Lung - blood supply
Lung - drug effects
Lung - metabolism
Lung - physiopathology
Lung Compliance - drug effects
Malondialdehyde - metabolism
Methylguanidine - metabolism
Rats
Rats, Sprague-Dawley
Reperfusion Injury - drug therapy
Reperfusion Injury - metabolism
Reperfusion Injury - physiopathology
Respiratory Insufficiency - metabolism
Respiratory Insufficiency - physiopathology
Respiratory Insufficiency - prevention & control
Surgery
Total Lung Capacity - drug effects
Tumor Necrosis Factor-alpha - metabolism
title Curcumin Attenuates Renal Ischemia and Reperfusion Injury–Induced Restrictive Respiratory Insufficiency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A26%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Curcumin%20Attenuates%20Renal%20Ischemia%20and%20Reperfusion%20Injury%E2%80%93Induced%20Restrictive%20Respiratory%20Insufficiency&rft.jtitle=Transplantation%20proceedings&rft.au=Yeh,%20J.-H&rft.date=2013-12-01&rft.volume=45&rft.issue=10&rft.spage=3542&rft.epage=3545&rft.pages=3542-3545&rft.issn=0041-1345&rft.eissn=1873-2623&rft_id=info:doi/10.1016/j.transproceed.2013.09.004&rft_dat=%3Cproquest_cross%3E1466373998%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-119a662c6e9c5dccadd5dae7a8a2f8b772f7a474ec2abedbcf938b4f0f6569983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1466373998&rft_id=info:pmid/24314954&rfr_iscdi=true